ncer accounts for 1,500 deaths each day in the United States. For decades, surgery, radiation and chemotherapy have been the predominant treatments against this disease. Fortunately, clinical trials over the last few years have shown that harnessing the body’s immune response and ability to fend off harmful bacteria and viruses through immunotherapies is a promising treatment option.
http://news.sys-con.com/node/3740512
OHC Provides Tri-State Patients with Access to Growing Number of Immunotherapy Clinical Trials